Abstract:Objective To investigate the clinical efficacy of posterior tibial nerve stimulation (PT-NS) for female patients with overactive bladder.Methods From Nov 2011 to Jan 2014,212 female patients with overactive bladder (OAB) were enrolled in this study,prospectively.They were randomly divided into three groups.In the PTNS group (n =70),patients received posterior tibial nerve stimulation therapy once a week for 12 weeks.In the M receptor blockers group (n =73),patients received M receptor blockers (Tolterodine Tartrate Tablets 2mg 2 times per day) for 12 weeks.In the combined treatment group (n =69),patients received PTNS combined with M receptor blockers therapy mentioned above for 12 weeks.The patients underwent a physiotherapeutic evaluation before and after the treatment that included the overactive bladder symptom score (OABSS),mean daily voiding episodes,mean daily incontinence episodes,et al.The PTNS group received the second 12 weeks' PTNS treatment,and part of the patients with an initial positive response to 24 weekly PTNS treatments continued the third round of PTNS therapy (once a week for 24 weeks and Once every 2 weeks for the next 24 weeks).Results During the first 12 weeks' treatment,the OABSS scores declined significantly after the treatment,compared to those before treatment,in each group (The M receptor blockers group:6.3±1.6 vs.8.7±1.8; The PTNS group:6.5±1.9 vs.8,8±1.7; The combined treatment group:5.8± 1.6 vs.8.9± 1.9,P＜0.05).The mean daily voiding episodes,mean nocturia episodes,mean daily incontinence episodes,daily urgency episodes and mean vloume per voiding declined significantly after treatment in each group (P＜0.05).There was no significantly difference in OABSS scores between PTNS group and M receptor blockers group after the treatment (P＞0.05).All recorded items declined significantly in the combined treatment group compared with the other two groups (P＜0.05).In the PTNS group,the OABSS felt from 6.5±1.9 to 6.1±1.9 (P＜0.05) at the end of the second 12 weeks' PTNS treatment.4 patients lost to follow-up in the first 12 weeks' PTNS treatment,4 patients dropped out the the second 12 weeks' PTNS treatment.After the second round treatment,43 patients showed good response to the PTNS treatment.The overall response rate was 69.4％ (43/62).Among them,22 patients continued the third round of PTNS therapy (once a week for 24 weeks and once every 2 weeks for the next 24 weeks).The OABSS scores were 6.4±2.1,6.5±2.2 after 24 and 48 weeks,respectively.Those results were similar to those in the first round treatment (6.4± 1.6,P ＞ 0.05).Conclusions PTNS provides good therapeutic effect for female primary ovcractive bladder.And the combination therapy provided significantly better outcomes than mono therapy.To those patients with an initial positive response,long-term treatment by using this technique could sustain overactive bladder symptom improvement.

Outcomes following percutaneous tibial nerve stimulation (PTNS) treatment for neurogenic and idiopathic overactive bladder

Percutaneous tibial nerve stimulation for the overactive bladder: A single‐arm trial

Percutaneous tibial nerve stimulation for idiopathic and neurogenic overactive bladder dysfunction: a four-year follow-up single-centre experience

The Investigation of Percutaneous Tibial Nerve Stimulation (PTNS) as a Minimally Invasive, Non-Surgical, Non-Hormonal Treatment for Overactive Bladder Symptoms

Percutaneous tibial nerve stimulation for overactive bladder syndrome: a systematic review and meta-analysis

Percutaneous versus Transcutaneous Electrical Stimulation of the Posterior Tibial Nerve in Idiopathic Overactive Bladder Syndrome with Urinary Incontinence in Adults: A Systematic Review

Posterior Tibial Nerve Stimulation for Overactive Bladder: Mechanism, Classification, and Management Outlines

A Prospective Observational Study of Posterior Tibial Nerve Stimulation in Multiple Sclerosis

New TENSI+ Device for Transcutaneous Posterior Tibial Nerve Stimulation: A Prospective, Multicentre, Post-market Clinical Study

Percutaneous Tibial Nerve Stimulation's Impact on Sexual Function in Female Patients with Neurogenic Detrusor Overactivity, Sexual Dysfunction, and Multiple Sclerosis

8 versus 12 weeks of percutaneous tibial nerve stimulation and response predictors for overactive bladder

Transcutaneous Tibial Nerve Stimulation in the Management of Overactive Bladder: A Scoping Review

Effectiveness of percutaneous posterior tibial nerve stimulation for the management of bowel dysfunction in multiple sclerosis patients

Efficacy and safety of tibial nerve stimulation using a wearable device for overactive bladder

Percutaneous tibial nerve stimulation versus sacral nerve stimulation for the treatment of faecal incontinence

Transcutaneous tibial nerve stimulation in patients with multiple sclerosis and overactive bladder: a real-life clinical and urodynamic assessment

Efficacy of Posterior Tibial Nerve Stimulation in Treating the Female Patients with Overactive Bladder

Tibial Nerve Stimulation for Urge Urinary Incontinence and Overactive Bladder: Narrative Review of Randomized Controlled Trials and Applicability to Implantable Devices

Short-term clinical and manometric outcomes of percutaneous tibial nerve stimulation for faecal incontinence: a large single-centre series

Effect of transcutaneous posterior tibial nerve stimulation and repetitive transcranial magnetic stimulation on neurogenic overactive bladder symptoms in female patients with multiple sclerosis: The study protocol of a randomized controlled study

Proximity of Percutaneous Tibial Nerve Stimulation Needle Insertion to Surrounding Anatomic Structures: A Cadaveric Study